Sleep Disordered Breathing in Interstitial Lung Disease: A Review
Overview
Authors
Affiliations
Patients with interstitial lung disease commonly exhibit abnormal sleep architecture and increased sleep fragmentation on polysomnography. Fatigue is a frequent complaint, and it is likely that poor sleep quality is a significant contributor. A number of studies have shown that sleep disordered breathing is prevalent in this population, particularly in the idiopathic pulmonary fibrosis subgroup. The factors that predispose these patients to obstructive sleep apnoea are not well understood, however it is believed that reduced caudal traction on the upper airway can enhance collapsibility. Ventilatory control system instability may also be an important factor, particularly in those with increased chemo-responsiveness, and in hypoxic conditions. Transient, repetitive nocturnal oxygen desaturation is frequently observed in interstitial lung disease, both with and without associated obstructive apnoeas. There is increasing evidence that sleep-desaturation is associated with increased mortality, and may be important in the pathogenesis of pulmonary hypertension in this population.
Roeder M, Sievi N, Schneider A, Osswald M, Malesevic S, Kolios A J Clin Sleep Med. 2022; 18(10):2415-2422.
PMID: 35855534 PMC: 9516590. DOI: 10.5664/jcsm.10140.
OSA and Chronic Respiratory Disease: Mechanisms and Epidemiology.
Locke B, Lee J, Sundar K Int J Environ Res Public Health. 2022; 19(9).
PMID: 35564882 PMC: 9105014. DOI: 10.3390/ijerph19095473.
Obstructive sleep apnea in sarcoidosis and impact of cpap treatment on fatigue.
Mari P, Pasciuto G, Siciliano M, Simonetti J, Ballacci F, Macagno F Sarcoidosis Vasc Diffuse Lung Dis. 2020; 37(2):169-178.
PMID: 33093780 PMC: 7569553. DOI: 10.36141/svdld.v37i2.9169.
Utpat K, Gupta A, Desai U, Joshi J, Bharmal R Lung India. 2020; 37(5):415-420.
PMID: 32883902 PMC: 7857377. DOI: 10.4103/lungindia.lungindia_6_20.
Comorbidity in idiopathic pulmonary fibrosis - what can biomarkers tell us?.
Alfaro T, Cordeiro C Ther Adv Respir Dis. 2020; 14:1753466620910092.
PMID: 32167024 PMC: 7074506. DOI: 10.1177/1753466620910092.